Epidemiology of Pysichiatric Disorders
DOI:
https://doi.org/10.62480/tjms.2022.vol12.pp102-105Keywords:
schizophrenia, mental disorde, depression, nervous systemAbstract
This article presents the epidemiology of mental disorder of several diseases such as anxiety disorders, schizophrenia, depression, bipolar disorder, post-traumatic stress disorder, eating disorders, destructive behavior and dissocial disorders and disorders of the nervous system development. The number of these diseases is shown
References
Institute of Health Metrics and Evaluation. Global Health Data Exchange (GHDx),
(https://vizhub.healthdata.org/gbd-results/, accessed 14 May 2022).
Mental Health and COVID-19: Early evidence of the pandemic’s impact. Geneva: World Health
Organization; 2022.
Charlson, F., van Ommeren, M., Flaxman, A., Cornett, J., Whiteford, H., & Saxena, S. New WHO
prevalence estimates of mental disorders in conflict settings: a systematic review and metaanalysis. Lancet. 2019; 394, 240–248.
Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annual Review
of Clinical Psychology, 2014; 10, 425-438.
Mental health atlas 2020. Geneva: World Health Organization; 2021
Moitra M, Santomauro D, Collins PY, Vos T, Whiteford H, Saxena S, et al. The global gap in
treatment coverage for major depressive disorder in 84 countries from 2000–2019: a systematic
review and Bayesian meta-regression analysis. PLoS Med.
;19(2):e1003901. doi:10.1371/journal.pmed.1003901.
Sanoev Z.I., Mirzayev Yu.R. Pharmacological Activity Of The Possessing New Atypical
Neuroleptics 1-Phenyltetrahydroiso-quinoline Structure. The American Journal of Medical Sciences
and Pharmaceutical Research Published: August 11, 2020 | Pages: 18-26
Doi: https://doi.org/10.37547/TAJMSPR/Volume02Issue08-03
Sanoev Z.I., Mirzayev Yu.R. Research of a new atypical neuroleptic 1-(3,4,-methylenedioxyphenyl)-
,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline on the
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
